SIRT1 and cancer: Specifically, SIRT6 induces MDM2-mediated degradation of SIRT1, thereby relieving the protective role of SIRT1 and allowing accumulation of reactive oxygen species (ROS), which ultimately drive cancer cell death [48] (Figure 2 and Table 1).